

BPC-157 + TB-500 Blend + GHK-Cu Set
BPC-157 + TB-500 Blend 10mg + GHK-Cu 50mg. A combined repair and dermal-matrix research set.


Bundle
Semax 10mg + Selank 10mg. The two most-cited nootropic research peptides in the Eastern European literature.
Select size
Quantity
Total
$90.00
That's the price. No inflated list, no permanent “discount” code to make it look cheaper than it is.
COA pending. The certificate for this lot will be uploaded to our COA library as soon as we have it.
Have a question?
For research use only. Not for human consumption.
Products supplied by Synthrex Biotech LLC are intended strictly for in-vitro laboratory research and development by qualified professionals. They are not drugs, foods, cosmetics, or dietary supplements, and are not approved by the FDA for human or veterinary use. They are not sold for, and must not be used for, human or animal consumption or administration of any kind. Synthrex Biotech LLC is not a compounding pharmacy or chemical compounding facility as defined under section 503A of the Federal Food, Drug, and Cosmetic Act, and is not an outsourcing facility as defined under section 503B of that Act. By purchasing, you affirm that you are a qualified researcher acquiring these materials for lawful research purposes only. A Safety Data Sheet (SDS/MSDS) is available on request for every compound.
Sold by Synthrex Biotech LLC. A Safety Data Sheet (SDS) is available on request at support@synthrexbiotech.com.
Every vial carries its own batch number, exactly as it would if bought separately. Every certificate is published and available for review. No published literature characterises this combination as a single entity.
An ACTH(4-10) analog studied in neuroprotection and cognitive-pathway research.
COA pending. The certificate for this lot will be uploaded to our COA library as soon as we have it.
Full research notes and sources for Semax →A tuftsin-derived heptapeptide investigated in anxiolytic and nootropic research literature.
Certificate of Analysis: SK10-01
Full research notes and sources for Selank →Semax is a synthetic heptapeptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in the 1980s. It is built from ACTH(4–10) — a fragment of adrenocorticotropic hormone already known to be behaviourally active but rapidly degraded — with a Pro-Gly-Pro tail added at the C-terminus specifically to slow enzymatic breakdown. Critically, the fragment was chosen because it lacks the corticotropic activity of full-length ACTH: the design intent was to keep the neuroactive portion and discard the hormonal one. It is listed in the Russian pharmacopoeia but has never been approved by the FDA or EMA.
The characterised biology sits in two areas. First, ACTH(4–10)-derived peptides interact with melanocortin receptors and with BDNF expression in rodent brain tissue. Second — and less widely appreciated — the N-terminal acetylation state of Semax substantially changes its coordination of copper(II) and zinc(II) ions, which a 2016 study in J Inorg Biochem tied to its biological properties. A 2021 rodent study examined behavioural and neurochemical measures following early-life fluvoxamine exposure. This is animal and in-vitro work; Semax is not FDA-approved for any use.
Selank comes from the same Russian institute and the same design logic as Semax, but from a different parent molecule. It is a synthetic analog of tuftsin — a four-residue immunomodulatory fragment (Thr-Lys-Pro-Arg) of the IgG heavy chain, discovered at Tufts University in the early 1970s and named after it. Selank adds a Pro-Gly-Pro tail to tuftsin for the same enzymatic-stability reason Semax carries one, producing a heptapeptide. It has been studied in Russia since the 1990s and appears in the literature under the development code TP-7.
Characterised in rodent models with attention to the GABAergic and monoaminergic systems, and examined in the literature as a peptide-based anxiolytic — a 2018 review in Protein & Peptide Letters addresses the molecular aspects specifically. Published rodent work has examined it in combination with diazepam under unpredictable chronic mild stress conditions, and separately in a morphine-withdrawal model. Because it derives from tuftsin, an immunologically active fragment, part of the literature concerns immune signalling rather than behaviour. All animal work; Selank is not FDA-approved for any use.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Summaries of published literature for research reference only. Not a claim about any product’s effect.
Batch releases & restocks
Every certificate is published and available for review. Join the Lab List and we'll tell you when a new one lands and when a sold-out compound is back — plus 15% off your first order, shown on screen the second you join.
Batch and restock notices from Synthrex Biotech LLC. No dosing advice, ever. One-click unsubscribe on every email.


BPC-157 + TB-500 Blend 10mg + GHK-Cu 50mg. A combined repair and dermal-matrix research set.


GLOW Blend 70mg + GHK-Cu 50mg. Copper-peptide focused preparation set for dermal research models.


KLOW Blend 80mg + KPV 10mg. A four-compound blend paired with an alpha-MSH fragment for multi-pathway research.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.